spacer

GO Term History: Displaying 212 audit records for all terms for the date 2012-06-14

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2012-06-14 GO:0097332 response to antipsychotic drug Added TERM response to antipsychotic drug
2012-06-14 GO:0097333 response to olanzapine Added TERM response to olanzapine
2012-06-14 GO:0097334 response to perphenazine Added TERM response to perphenazine
2012-06-14 GO:0097335 response to quetiapine Added TERM response to quetiapine
2012-06-14 GO:0097336 response to risperidone Added TERM response to risperidone
2012-06-14 GO:0097337 response to ziprasidone Added TERM response to ziprasidone
2012-06-14 GO:0097338 response to clozapine Added TERM response to clozapine
2012-06-14 GO:0097339 glycolate transmembrane transport Added TERM glycolate transmembrane transport
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added TERM somatostatin receptor signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added TERM somatostatin signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added TERM cannabinoid signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added TERM interleukin-33-mediated signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added TERM interleukin-17A-mediated signaling pathway
2012-06-14 GO:0038174 interleukin-17A receptor activity Added TERM interleukin-17A receptor activity
2012-06-14 GO:1900866 glycolate transport Added TERM glycolate transport
2012-06-14 GO:1900867 sarcinapterin metabolic process Added TERM sarcinapterin metabolic process
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added TERM sarcinapterin biosynthetic process
2012-06-14 GO:1900869 tatiopterin metabolic process Added TERM tatiopterin metabolic process
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added TERM tatiopterin biosynthetic process
2012-06-14 GO:1900871 chloroplast mRNA modification Added TERM chloroplast mRNA modification
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM SST receptor activity
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM growth hormone-inhibiting hormone receptor activity
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM GPCR signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM SRIF signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid receptor signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM interleukin-33 signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM interleukin-33-mediated signalling pathway
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin formation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM GPCR signalling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin-activated somatostatin receptor signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid-activated signaling pathway
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid degradation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM GPCR protein signaling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 catabolism
2012-06-14 GO:0004994 somatostatin receptor activity Deleted DEFINITION Combining with somatostatin to initiate a change in cell activity.
2012-06-14 GO:0071010 prespliceosome Deleted DEFINITION A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation.
2012-06-14 GO:0004994 somatostatin receptor activity Added DEFINITION Combining with somatostatin to initiate a change in cell activity. Somatostatin is a peptide hormone that regulates the endocrine system by signaling via G-protein coupled somatostatin receptors. Somatostatin has two active forms produced by proteolytic cleavage: a 14 amino acid peptide (SST-14) and a 28 amino acid peptide (SST-28).
2012-06-14 GO:0071010 prespliceosome Added DEFINITION A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Prespliceosome complexes are not active for splicing, but are instead an early step in the assembly of a spliceosomal complex.
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2'-deoxyuridine stimulus. 5-fluoro-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added DEFINITION A series of molecular signals initiated by the binding of interleukin-17A to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0038174 interleukin-17A receptor activity Added DEFINITION Combining with the cytokine interleukin-17A and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
2012-06-14 GO:0097328 response to carboplatin Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carboplatin stimulus.
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added DEFINITION Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under salt stress. The stress is usually an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
2012-06-14 GO:1900866 glycolate transport Added DEFINITION The directed movement of a glycolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added DEFINITION The chemical reactions and pathways resulting in the formation of sarcinapterin.
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added DEFINITION Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a menadione stimulus. Menadione (also called vitamin K3) is a naphthoquinone having a methyl substituent at the 2-position.
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added DEFINITION A series of molecular signals initiated by the binding of interleukin-33 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0097337 response to ziprasidone Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.
2012-06-14 GO:1900871 chloroplast mRNA modification Added DEFINITION The covalent alteration within the chloroplast of one or more nucleotides within an mRNA to produce an mRNA molecule with a sequence that differs from that coded genetically.
2012-06-14 GO:0097329 response to antimetabolite Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimetabolite stimulus. An antimetabolite is a substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
2012-06-14 GO:0097331 response to cytarabine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.
2012-06-14 GO:0097332 response to antipsychotic drug Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
2012-06-14 GO:0097333 response to olanzapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.
2012-06-14 GO:0097339 glycolate transmembrane transport Added DEFINITION A process in which glycolate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).
2012-06-14 GO:1900867 sarcinapterin metabolic process Added DEFINITION The chemical reactions and pathways involving sarcinapterin.
2012-06-14 GO:0004949 cannabinoid receptor activity Added DEFINITION Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.
2012-06-14 GO:0097334 response to perphenazine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
2012-06-14 GO:1900869 tatiopterin metabolic process Added DEFINITION The chemical reactions and pathways involving tatiopterin.
2012-06-14 GO:0038170 somatostatin signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of the peptide somatostatin (SST) binding to a somatostatin receptor (SSTR). The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0038171 cannabinoid signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of a cannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.
2012-06-14 GO:0071926 endocannabinoid signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of an endocannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription. Endocannabinoids are small molecules derived from arachidonic acid, anandamide (arachidonoylethanolamide) and 2-arachidonoylglycerol.
2012-06-14 GO:0097327 response to antineoplastic agent Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antineoplastic agent stimulus. An antineoplastic agent is a substance that inhibits or prevents the proliferation of neoplasms.
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of a somatostatin receptor (SSTR) binding to one of its physiological ligands and transmitting the signal to a heterotrimeric G-protein complex. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0097335 response to quetiapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.
2012-06-14 GO:0097336 response to risperidone Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.
2012-06-14 GO:0097338 response to clozapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added DEFINITION The chemical reactions and pathways resulting in the formation of tatiopterin.
2012-06-14 GO:0004949 cannabinoid receptor activity Deleted DEFINITION Combining with cannabinoids to initiate a change in cell activity.
2012-06-14 GO:0071926 endocannabinoid signaling pathway Deleted DEFINITION The series of molecular signals generated as a consequence of an endocannabinoid binding to a cell surface receptor. Endocannabinoids are small molecules derived from arachidonic acid, anandamide (arachidonoylethanolamide) and 2-arachidonoylglycerol.
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added TERM positive regulation of transcription from RNA polymerase II promoter in response to salt stress
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added TERM positive regulation of transcription from RNA polymerase II promoter in response to menadione
2012-06-14 GO:0097327 response to antineoplastic agent Added TERM response to antineoplastic agent
2012-06-14 GO:0097328 response to carboplatin Added TERM response to carboplatin
2012-06-14 GO:0097329 response to antimetabolite Added TERM response to antimetabolite
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added TERM response to 5-fluoro-2'-deoxyuridine
2012-06-14 GO:0097331 response to cytarabine Added TERM response to cytarabine
2012-06-14 GO:1900867 sarcinapterin metabolic process Added SYNONYM sarcinapterin metabolism
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin anabolism
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM GHIH receptor activity
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM SRIF receptor activity
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added SYNONYM SST receptor signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM SST signaling pathway
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added SYNONYM SSTR signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM IL-33-mediated signaling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N catabolism
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM GPCR protein signalling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid catabolic process
2012-06-14 GO:1900864 mitochondrial RNA modification Deleted SYNONYM mitochondrial RNA modification
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 degradation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM G-protein coupled receptor protein signalling pathway
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid breakdown
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL17A signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM interleukin-17A-mediated signalling pathway
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin biosynthesis
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolic process
2012-06-14 GO:1900866 glycolate transport Added RELATION is a GO:0015718 (monocarboxylic acid transport)
2012-06-14 GO:1900867 sarcinapterin metabolic process Added RELATION is a GO:2001115 (methanopterin-containing compound metabolic process)
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added RELATION is a GO:2001116 (methanopterin-containing compound biosynthetic process)
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added RELATION is a GO:1900867 (sarcinapterin metabolic process)
2012-06-14 GO:1900869 tatiopterin metabolic process Added RELATION is a GO:0042558 (pteridine-containing compound metabolic process)
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added RELATION is a GO:1900869 (tatiopterin metabolic process)
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added RELATION is a GO:0042559 (pteridine-containing compound biosynthetic process)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION is a GO:1900865 (chloroplast RNA modification)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION is a GO:0016556 (mRNA modification)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION occurs in GO:0009507 (chloroplast)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Added RELATION is a GO:0036251 (positive regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Deleted RELATION is a GO:0061416 (regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Deleted RELATION is a GO:0061393 (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress)
2012-06-14 GO:0097327 response to antineoplastic agent Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097328 response to carboplatin Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097329 response to antimetabolite Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097331 response to cytarabine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097332 response to antipsychotic drug Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097333 response to olanzapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097334 response to perphenazine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097335 response to quetiapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097336 response to risperidone Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097337 response to ziprasidone Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097338 response to clozapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097339 glycolate transmembrane transport Added RELATION is a GO:0034220 (ion transmembrane transport)
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0038170 somatostatin signaling pathway Added RELATION is a GO:0038169 (somatostatin receptor signaling pathway)
2012-06-14 GO:0038170 somatostatin signaling pathway Added RELATION is a GO:0009755 (hormone-mediated signaling pathway)
2012-06-14 GO:0038171 cannabinoid signaling pathway Added RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added RELATION is a GO:0019221 (cytokine-mediated signaling pathway)
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added RELATION is a GO:0019221 (cytokine-mediated signaling pathway)
2012-06-14 GO:0038174 interleukin-17A receptor activity Added RELATION part of GO:0038173 (interleukin-17A-mediated signaling pathway)
2012-06-14 GO:0038174 interleukin-17A receptor activity Added RELATION is a GO:0030368 (interleukin-17 receptor activity)
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added RELATION is a GO:0061416 (regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added RELATION is a GO:0061393 (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress)
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added RELATION is a GO:0036245 (cellular response to menadione)
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added RELATION is a GO:0036003 (positive regulation of transcription from RNA polymerase II promoter in response to stress)
2012-06-14 GO:0071926 endocannabinoid signaling pathway Added RELATION is a GO:0038171 (cannabinoid signaling pathway)
2012-06-14 GO:0071926 endocannabinoid signaling pathway Deleted RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0002114 interleukin-33 receptor activity Added RELATION part of GO:0038172 (interleukin-33-mediated signaling pathway)
2012-06-14 GO:0004994 somatostatin receptor activity Added RELATION part of GO:0038170 (somatostatin signaling pathway)
2012-06-14 GO:0004949 cannabinoid receptor activity Added RELATION part of GO:0038171 (cannabinoid signaling pathway)
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatotrophin release inhibiting factor signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM interleukin-17A signaling pathway
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin formation
2012-06-14 GO:0071010 prespliceosome Added SYNONYM prespliceosome
2012-06-14 GO:1900869 tatiopterin metabolic process Added SYNONYM tatiopterin metabolism
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin synthesis
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin-mediated signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid-mediated signaling pathway
2012-06-14 GO:1900871 chloroplast mRNA modification Added SYNONYM chloroplast mRNA editing
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin synthesis
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin anabolism
2012-06-14 GO:0004949 cannabinoid receptor activity Added SYNONYM endocannabinoid receptor activity
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin signalling pathway
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin biosynthesis
2012-06-14 GO:1900871 chloroplast mRNA modification Added SYNONYM mRNA editing in chloroplast
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM somatotrophin release inhibiting factor receptor activity
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM G-protein coupled receptor signalling pathway
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added SYNONYM positive regulation of transcription from RNA polymerase II promoter in response to menadione stress
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM IL33 signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL-17A-mediated signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL17a signaling pathway

Terms

Timestamp GO ID GO Term Name Action Category Detail
2012-06-14 GO:0097332 response to antipsychotic drug Added TERM response to antipsychotic drug
2012-06-14 GO:0097333 response to olanzapine Added TERM response to olanzapine
2012-06-14 GO:0097334 response to perphenazine Added TERM response to perphenazine
2012-06-14 GO:0097335 response to quetiapine Added TERM response to quetiapine
2012-06-14 GO:0097336 response to risperidone Added TERM response to risperidone
2012-06-14 GO:0097337 response to ziprasidone Added TERM response to ziprasidone
2012-06-14 GO:0097338 response to clozapine Added TERM response to clozapine
2012-06-14 GO:0097339 glycolate transmembrane transport Added TERM glycolate transmembrane transport
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added TERM somatostatin receptor signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added TERM somatostatin signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added TERM cannabinoid signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added TERM interleukin-33-mediated signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added TERM interleukin-17A-mediated signaling pathway
2012-06-14 GO:0038174 interleukin-17A receptor activity Added TERM interleukin-17A receptor activity
2012-06-14 GO:1900866 glycolate transport Added TERM glycolate transport
2012-06-14 GO:1900867 sarcinapterin metabolic process Added TERM sarcinapterin metabolic process
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added TERM sarcinapterin biosynthetic process
2012-06-14 GO:1900869 tatiopterin metabolic process Added TERM tatiopterin metabolic process
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added TERM tatiopterin biosynthetic process
2012-06-14 GO:1900871 chloroplast mRNA modification Added TERM chloroplast mRNA modification
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added TERM positive regulation of transcription from RNA polymerase II promoter in response to salt stress
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added TERM positive regulation of transcription from RNA polymerase II promoter in response to menadione
2012-06-14 GO:0097327 response to antineoplastic agent Added TERM response to antineoplastic agent
2012-06-14 GO:0097328 response to carboplatin Added TERM response to carboplatin
2012-06-14 GO:0097329 response to antimetabolite Added TERM response to antimetabolite
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added TERM response to 5-fluoro-2'-deoxyuridine
2012-06-14 GO:0097331 response to cytarabine Added TERM response to cytarabine

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM SST receptor activity
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM growth hormone-inhibiting hormone receptor activity
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM GPCR signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM SRIF signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid receptor signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM interleukin-33 signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM interleukin-33-mediated signalling pathway
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin formation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM GPCR signalling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin-activated somatostatin receptor signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid-activated signaling pathway
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid degradation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM GPCR protein signaling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 catabolism
2012-06-14 GO:0004994 somatostatin receptor activity Deleted DEFINITION Combining with somatostatin to initiate a change in cell activity.
2012-06-14 GO:0071010 prespliceosome Deleted DEFINITION A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation.
2012-06-14 GO:0004994 somatostatin receptor activity Added DEFINITION Combining with somatostatin to initiate a change in cell activity. Somatostatin is a peptide hormone that regulates the endocrine system by signaling via G-protein coupled somatostatin receptors. Somatostatin has two active forms produced by proteolytic cleavage: a 14 amino acid peptide (SST-14) and a 28 amino acid peptide (SST-28).
2012-06-14 GO:0071010 prespliceosome Added DEFINITION A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Prespliceosome complexes are not active for splicing, but are instead an early step in the assembly of a spliceosomal complex.
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2'-deoxyuridine stimulus. 5-fluoro-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added DEFINITION A series of molecular signals initiated by the binding of interleukin-17A to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0038174 interleukin-17A receptor activity Added DEFINITION Combining with the cytokine interleukin-17A and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
2012-06-14 GO:0097328 response to carboplatin Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carboplatin stimulus.
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added DEFINITION Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under salt stress. The stress is usually an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
2012-06-14 GO:1900866 glycolate transport Added DEFINITION The directed movement of a glycolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added DEFINITION The chemical reactions and pathways resulting in the formation of sarcinapterin.
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added DEFINITION Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a menadione stimulus. Menadione (also called vitamin K3) is a naphthoquinone having a methyl substituent at the 2-position.
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added DEFINITION A series of molecular signals initiated by the binding of interleukin-33 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0097337 response to ziprasidone Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.
2012-06-14 GO:1900871 chloroplast mRNA modification Added DEFINITION The covalent alteration within the chloroplast of one or more nucleotides within an mRNA to produce an mRNA molecule with a sequence that differs from that coded genetically.
2012-06-14 GO:0097329 response to antimetabolite Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimetabolite stimulus. An antimetabolite is a substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
2012-06-14 GO:0097331 response to cytarabine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.
2012-06-14 GO:0097332 response to antipsychotic drug Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
2012-06-14 GO:0097333 response to olanzapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.
2012-06-14 GO:0097339 glycolate transmembrane transport Added DEFINITION A process in which glycolate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).
2012-06-14 GO:1900867 sarcinapterin metabolic process Added DEFINITION The chemical reactions and pathways involving sarcinapterin.
2012-06-14 GO:0004949 cannabinoid receptor activity Added DEFINITION Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.
2012-06-14 GO:0097334 response to perphenazine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
2012-06-14 GO:1900869 tatiopterin metabolic process Added DEFINITION The chemical reactions and pathways involving tatiopterin.
2012-06-14 GO:0038170 somatostatin signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of the peptide somatostatin (SST) binding to a somatostatin receptor (SSTR). The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0038171 cannabinoid signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of a cannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.
2012-06-14 GO:0071926 endocannabinoid signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of an endocannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription. Endocannabinoids are small molecules derived from arachidonic acid, anandamide (arachidonoylethanolamide) and 2-arachidonoylglycerol.
2012-06-14 GO:0097327 response to antineoplastic agent Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antineoplastic agent stimulus. An antineoplastic agent is a substance that inhibits or prevents the proliferation of neoplasms.
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added DEFINITION The series of molecular signals generated as a consequence of a somatostatin receptor (SSTR) binding to one of its physiological ligands and transmitting the signal to a heterotrimeric G-protein complex. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
2012-06-14 GO:0097335 response to quetiapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.
2012-06-14 GO:0097336 response to risperidone Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.
2012-06-14 GO:0097338 response to clozapine Added DEFINITION Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added DEFINITION The chemical reactions and pathways resulting in the formation of tatiopterin.
2012-06-14 GO:0004949 cannabinoid receptor activity Deleted DEFINITION Combining with cannabinoids to initiate a change in cell activity.
2012-06-14 GO:0071926 endocannabinoid signaling pathway Deleted DEFINITION The series of molecular signals generated as a consequence of an endocannabinoid binding to a cell surface receptor. Endocannabinoids are small molecules derived from arachidonic acid, anandamide (arachidonoylethanolamide) and 2-arachidonoylglycerol.
2012-06-14 GO:1900867 sarcinapterin metabolic process Added SYNONYM sarcinapterin metabolism
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin anabolism
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM GHIH receptor activity
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM SRIF receptor activity
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added SYNONYM SST receptor signaling pathway
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM SST signaling pathway
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added SYNONYM SSTR signaling pathway
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM IL-33-mediated signaling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChIKey=MDFZYGLOIJNNRM-OAJDADRGSA-N catabolism
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM GPCR protein signalling pathway
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid catabolic process
2012-06-14 GO:1900864 mitochondrial RNA modification Deleted SYNONYM mitochondrial RNA modification
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChIKey=RWQKHEORZBHNRI-BMIGLBTASA-N catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(O)=O)c(O)c2C(=O)O1 breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM InChI=1S/C33H44O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1 degradation
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Deleted SYNONYM G-protein coupled receptor protein signalling pathway
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 catabolic process
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-(((3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM (-)-N-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (4alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17beta)-6,16- bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid breakdown
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL17A signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM interleukin-17A-mediated signalling pathway
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin biosynthesis
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM C20H18ClNO6 breakdown
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM (2Z)-2-[(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-diacetoxy-4,8,10,14-tetramethyl-3,7-dioxogon-1-en-17-ylidene]-6-methylhept-5-enoic acid breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM C33H44O8 degradation
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O catabolic process
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM [H][C@@]12CC[C@@]3([H])[C@@]4(C)C=CC(=O)[C@@H](C)[C@]4([H])[C@H](OC(C)=O)C(=O)[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)C2=C(CCC=C(C)C)C(O)=O breakdown
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine degradation
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 catabolism
2012-06-14 GO:1900817 ochratoxin A catabolic process Deleted SYNONYM N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl]carbonyl}-L-phenylalanine catabolism
2012-06-14 GO:1900811 helvolic acid catabolic process Deleted SYNONYM 16-(Acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid catabolic process
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatotrophin release inhibiting factor signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM interleukin-17A signaling pathway
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin formation
2012-06-14 GO:0071010 prespliceosome Added SYNONYM prespliceosome
2012-06-14 GO:1900869 tatiopterin metabolic process Added SYNONYM tatiopterin metabolism
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin synthesis
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin-mediated signaling pathway
2012-06-14 GO:0038171 cannabinoid signaling pathway Added SYNONYM cannabinoid-mediated signaling pathway
2012-06-14 GO:1900871 chloroplast mRNA modification Added SYNONYM chloroplast mRNA editing
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added SYNONYM sarcinapterin synthesis
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin anabolism
2012-06-14 GO:0004949 cannabinoid receptor activity Added SYNONYM endocannabinoid receptor activity
2012-06-14 GO:0038170 somatostatin signaling pathway Added SYNONYM somatostatin signalling pathway
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added SYNONYM tatiopterin biosynthesis
2012-06-14 GO:1900871 chloroplast mRNA modification Added SYNONYM mRNA editing in chloroplast
2012-06-14 GO:0004994 somatostatin receptor activity Added SYNONYM somatotrophin release inhibiting factor receptor activity
2012-06-14 GO:0007186 G-protein coupled receptor signaling pathway Added SYNONYM G-protein coupled receptor signalling pathway
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added SYNONYM positive regulation of transcription from RNA polymerase II promoter in response to menadione stress
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added SYNONYM IL33 signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL-17A-mediated signaling pathway
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added SYNONYM IL17a signaling pathway

Relationships

Timestamp GO ID GO Term Name Action Category Detail
2012-06-14 GO:1900866 glycolate transport Added RELATION is a GO:0015718 (monocarboxylic acid transport)
2012-06-14 GO:1900867 sarcinapterin metabolic process Added RELATION is a GO:2001115 (methanopterin-containing compound metabolic process)
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added RELATION is a GO:2001116 (methanopterin-containing compound biosynthetic process)
2012-06-14 GO:1900868 sarcinapterin biosynthetic process Added RELATION is a GO:1900867 (sarcinapterin metabolic process)
2012-06-14 GO:1900869 tatiopterin metabolic process Added RELATION is a GO:0042558 (pteridine-containing compound metabolic process)
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added RELATION is a GO:1900869 (tatiopterin metabolic process)
2012-06-14 GO:1900870 tatiopterin biosynthetic process Added RELATION is a GO:0042559 (pteridine-containing compound biosynthetic process)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION is a GO:1900865 (chloroplast RNA modification)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION is a GO:0016556 (mRNA modification)
2012-06-14 GO:1900871 chloroplast mRNA modification Added RELATION occurs in GO:0009507 (chloroplast)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Added RELATION is a GO:0036251 (positive regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Deleted RELATION is a GO:0061416 (regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0061404 positive regulation of transcription from RNA polymerase II promoter in response to increased salt Deleted RELATION is a GO:0061393 (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress)
2012-06-14 GO:0097327 response to antineoplastic agent Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097328 response to carboplatin Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097329 response to antimetabolite Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097330 response to 5-fluoro-2'-deoxyuridine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097331 response to cytarabine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097332 response to antipsychotic drug Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097333 response to olanzapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097334 response to perphenazine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097335 response to quetiapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097336 response to risperidone Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097337 response to ziprasidone Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097338 response to clozapine Added RELATION is a GO:0042221 (response to chemical)
2012-06-14 GO:0097339 glycolate transmembrane transport Added RELATION is a GO:0034220 (ion transmembrane transport)
2012-06-14 GO:0038169 somatostatin receptor signaling pathway Added RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0038170 somatostatin signaling pathway Added RELATION is a GO:0038169 (somatostatin receptor signaling pathway)
2012-06-14 GO:0038170 somatostatin signaling pathway Added RELATION is a GO:0009755 (hormone-mediated signaling pathway)
2012-06-14 GO:0038171 cannabinoid signaling pathway Added RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0038172 interleukin-33-mediated signaling pathway Added RELATION is a GO:0019221 (cytokine-mediated signaling pathway)
2012-06-14 GO:0038173 interleukin-17A-mediated signaling pathway Added RELATION is a GO:0019221 (cytokine-mediated signaling pathway)
2012-06-14 GO:0038174 interleukin-17A receptor activity Added RELATION part of GO:0038173 (interleukin-17A-mediated signaling pathway)
2012-06-14 GO:0038174 interleukin-17A receptor activity Added RELATION is a GO:0030368 (interleukin-17 receptor activity)
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added RELATION is a GO:0061416 (regulation of transcription from RNA polymerase II promoter in response to salt stress)
2012-06-14 GO:0036251 positive regulation of transcription from RNA polymerase II promoter in response to salt stress Added RELATION is a GO:0061393 (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress)
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added RELATION is a GO:0036245 (cellular response to menadione)
2012-06-14 GO:0036252 positive regulation of transcription from RNA polymerase II promoter in response to menadione Added RELATION is a GO:0036003 (positive regulation of transcription from RNA polymerase II promoter in response to stress)
2012-06-14 GO:0071926 endocannabinoid signaling pathway Added RELATION is a GO:0038171 (cannabinoid signaling pathway)
2012-06-14 GO:0071926 endocannabinoid signaling pathway Deleted RELATION is a GO:0007186 (G-protein coupled receptor signaling pathway)
2012-06-14 GO:0002114 interleukin-33 receptor activity Added RELATION part of GO:0038172 (interleukin-33-mediated signaling pathway)
2012-06-14 GO:0004994 somatostatin receptor activity Added RELATION part of GO:0038170 (somatostatin signaling pathway)
2012-06-14 GO:0004949 cannabinoid receptor activity Added RELATION part of GO:0038171 (cannabinoid signaling pathway)
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
91ms